Valuation: Valbiotis

Market Cap 18.71M 21.4M 17.26M 15.87M 30.07M 2.06B 30.58M 206M 80.86M 1.01B 80.38M 78.62M 3.47B P/E 2026 *
-2.54x
P/E 2027 * -9.89x
Enterprise Value 19.91M 22.78M 18.37M 16.89M 32M 2.19B 32.54M 219M 86.05M 1.07B 85.53M 83.66M 3.69B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 1.25x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day-1.26%
1 week-2.98%
Current month-2.86%
1 month-12.35%
3 months-26.74%
6 months+11.57%
Current year+12.54%
1 week 0.78
Extreme 0.777
0.84
1 month 0.74
Extreme 0.735
0.9
Current year 0.65
Extreme 0.653
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 29/02/2024
Chief Tech/Sci/R&D Officer - 31/08/2017
Director TitleAgeSince
Chairman 55 28/02/2017
Director/Board Member - 25/10/2017
Director/Board Member - 17/03/2019
Date Insider Type Main position Quantity % Market Cap.
27/01/22Others

Founder

42,480 0.4364%
27/01/22Fiscal year

Founder

2,095 0.0215%
09/07/21Fiscal year

Chief Technology Officer

2,000 0.0206%
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%-2.98%-4.99%-81.67% 21.41M
-1.39%-7.58%+54.00%+124.73% 54.49B
+3.13%+11.16%+67.30%+94.35% 55.93B
-0.27%-5.77%+6.75%+430.48% 23.87B
+1.76%-1.65%-16.86%-14.20% 22.86B
+3.51%+7.50%+47.81%-3.33% 20B
+1.94%+0.21%+39.31%-29.41% 17.48B
+10.00%-2.06%+210.10%+370.99% 15.39B
+7.69%+4.38%+56.51%+712.88% 15.19B
-0.39%-1.00%+26.08%+189.47% 14.02B
Average +2.47%+0.13%+48.60%+179.43% 23.93B
Weighted average by Cap. +2.10%+0.47%+52.59%+169.86%

Financials

2026 *2027 *
Net sales 3.85M 4.4M 3.55M 3.26M 6.19M 424M 6.29M 42.4M 16.64M 207M 16.54M 16.17M 714M 13.25M 15.15M 12.22M 11.24M 21.29M 1.46B 21.65M 146M 57.26M 713M 56.91M 55.67M 2.46B
Net income -8.75M -10.01M -8.07M -7.42M -14.06M -963M -14.3M -96.36M -37.81M -471M -37.58M -36.76M -1.62B -5.35M -6.12M -4.94M -4.54M -8.6M -589M -8.74M -58.92M -23.12M -288M -22.98M -22.48M -992M
Net Debt 1.2M 1.37M 1.11M 1.02M 1.93M 132M 1.96M 13.22M 5.19M 64.55M 5.15M 5.04M 222M -2.1M -2.4M -1.94M -1.78M -3.37M -231M -3.43M -23.13M -9.07M -113M -9.02M -8.82M -389M
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
15/07/26 0.7810 -1.26% 75,820
14/07/26 €0.7910 -0.50% 29,738
13/07/26 €0.7950 +0.63% 24,020
10/07/26 €0.7900 +1.67% 30,614
09/07/26 €0.7770 -3.48% 91,000
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7910EUR
Average target price
2.228EUR
Spread / Average Target
+181.62%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALVAL Stock